pembrolizumab,atezolizumab,vibostolimab,nivolumab,favezelimab
bms,merck,roche
['urothelial', 'urothelial carcinoma', 'key,note,57', 'imvigor130', 'check,mate,274', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
this afternoon's session on urothelial carcinoma featured several highly-anticipated presentations, including os data from imvigor130, results from cohort b of keynote-057, and extended follow-up from checkmate 274. to find out more, visit #gu23 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.